NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

That's all true, but it is too cumbersome a process and if anything shows why going it alone was almost certainly a mistake there's now almost no chance long time shareholders will benefit from DCVax L by the time we're done with serial toxic dilution a reverse split etc.

A company with a market cap of less than 1 billion will almost always fail its Phase 3 trial per the Feuerstein-Rutain Rule.

What are the odds for one at 100 million or less?